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Assistant Professor Pinckney Johnstone 
(John) Maxwell IV, MD, is a colorectal 
surgeon who strikes the delicate balance 
of saving lives, winning his patients’ 
trust, advising students, and expanding 
Jefferson’s community presence. In 
addition to performing surgery and seeing 
patients, Dr. Maxwell is also actively 
involved as faculty advisor to the Gibbon 
Surgical Society, comprised of hundreds 
of aspiring medical students at Jefferson 
(see “About the Surgeon” at right). 
“People did the same for me in my 
training,” says Dr. Maxwell, “and I feel 
it’s my responsibility to give back as 
much as I can.” A South Carolina native, 
Dr. Maxwell was fellowship-trained at 
Jefferson; he earned his medical degree 
from the Medical University of South 
Carolina and completed his residency 
at Louisiana State University in New 
Orleans. His daughter was born two days 
before Hurricane Katrina, and he spent 
the next two years working in the heart of 
“Cajun country” in Lafayette, Louisiana. 
“That’s where I began to see the subtle 
differences in caring for patients in 
a community setting as opposed to a 
large urban center,” says Dr. Maxwell. 
He is now helping expand the Jefferson 
colorectal surgery practice to Methodist 
Hospital, a community-based hospital in 
South Philadelphia. He spends a day there 
each week in the OR and on endoscopic 
cases, and trains medical students on the 
Methodist rotation. For another weekly 
half-day, Dr. Maxwell offers prophylactic 
colorectal care in an office setting at St. 
Agnes Medical Center, also on South 
Broad Street. 
Dr. Maxwell knows only too well that 
colorectal surgery can be a matter of 
life and death. Gene Benko, 72, came to 
Jefferson in an ambulance from Toms 
River, NJ, in September 2009 with a 
massive lower GI bleed. “I was in such 
critical condition that a priest came twice 
to read me my last rights,” recalls Mr. 
Benko. He interviewed three medical 
teams when he arrived at Jefferson before 
choosing Dr. Maxwell, “because he was 
young, and energetic,” Mr. Benko says. 
Ultimately Dr. Maxwell needed to 
perform a laparoscopic total abdominal 
colectomy. “He was there when I woke 
up,” says Mr. Benko “with the good (and 
bad) news” that he had been able to stop 
the bleeding and save Mr. Benko’s life, 
but removing the entire colon required an 
ileostomy—a procedure that brings the 
intestine to the surface of the abdomen, 
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With Dr. Maxwell’s help, Gene Benko of Toms River, NJ, has come a long way since he 
arrived at Jefferson with a gastrointestinal hemorrhage in September 2009.
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Officers of the Gibbon Surgical Society 
stand in front of the portrait of John H. 
Gibbon Jr., MD hanging in 620 Curtis. 
Pictured are Jordan Bloom, President; 
Rachel Choron, Vice President; Fiona 
Chory, Technical Skills Coordinator; and 
Patrick Hartendorp, Education Coordinator.
I know so many students who speak highly 
of Dr. Maxwell. We are fortunate to have him 
serve as the faculty advisor to our society. 
The students on his service love him. He 
goes out of his way to bring students into 
a surgical case and makes sure that every 
student feels that his or her involvement 
matters to the team. He offers a lot of positive 
reinforcement and helps to create incredible 
opportunities for the many Jefferson students 
considering a surgical career. 
At our first Gibbon Society meeting of the 
year, he gave out his cell phone number to a 
handful of newly elected students he’d just 
met, inviting us to contact him any time. As 
we plan the year’s activities, he’s always 
available—even on weekends—to answer 
questions or offer advice. Because he is so 
generous with his time and expertise, the 
students benefit tremendously from direct 
access to a surgeon of his caliber.
–Jordan Bloom, JMC Class of 2011
The Gibbon Surgical Society promotes surgery  
to medical students on campus through lectures  
and events. John H. Gibbon Jr., MD, Jefferson 
professor and chairman of surgery (1956-1967), 
is renowned in medical history as the inventor of 
the heart-lung machine, which made possible the 
world’s first successful open-heart operation at 
Jefferson in 1953. Dr. Gibbon focused international 
attention on Jefferson by ushering in a new era  
of cardiac surgery. 
About the Surgeon
to emit intestinal waste. “A small price to 
pay to be alive,” says Mr. Benko. 
Three months later Dr. Maxwell 
performed another surgery to close and 
reattach the intestine. Despite some 
complications, which required a third 
procedure, Mr. Benko is extremely 
grateful for the care he received. “I chose 
the right surgeon,” he says. “Dr. Maxwell 
is extremely conscientious. I know I’m 
in good hands, and I’m determined to 
get myself better with his help.” While 
Mr. Benko sees an internist and other 
specialists closer to his home near Toms 
River, he says he will always make the  
trip to Philadelphia to see his surgeon  
of choice.
Read more about Gene Benko’s story at 
www.jeffersonhospital.org/genebenko
“I chose the right surgeon. 
Dr. Maxwell is extremely 
conscientious. I know I’m 
in good hands.”
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Samuel D. Gross Professor and  
Chair, Department of Surgery
Summer reading! 
Mixed amongst the thrillers that I read this 
summer, two important nonfiction works 
held my attention. Both focused on a topic of 
interest to all of us – improvement of the U.S. 
health care “system”.
First, former Senate majority leader Tom 
Daschle, in his short book Critical: What We 
Can Do About The Health-Care Crisis gives 
us an abbreviated history of past health 
care reform in America, cautiously uses 
patients’ sad stories to depict the current 
crisis, nicely portrays the complexities of 
our “system”, and proposes a solution 
which is analogous to the Federal Reserve 
Board (which oversees our very complicated 
financial system). Daschle’s thesis is that 
a Fed-like Health Board would insulate our 
health care delivery system from political 
pressure, insure that experts review policy 
and share accountability, and could lead 
to an improved standard of care for our 
patients, at a lower cost.
Second, best selling author and surgeon 
Atul Gawande, in his book The Checklist 
Manifesto: How To Get Things Right nicely 
shows just how complex the care of our 
patients has become with modern medicine. 
He argues that the era of the Middle Ages’ 
“master builder” has necessarily ended, 
as current day management of patients 
exceeds the ability of even the most talented 
clinician to provide all encompassing 
care. Using lessons from the airline and 
space industries, Gawande shows how 
the implementation of specific, focused 
checklists have yielded remarkable success – 
decreasing the incidence of central line 
infections, improving ICU care, and in the 
operating room: reducing errors, wrong-site 
surgery, retained foreign bodies and overall 
mortality rates.
Both of these books are concise and quick 
reads. In my mind, both are required reading 
for physicians whose ultimate goal is to 
improve the care delivered to our patients. 
Since the Jefferson Vascular Center was 
launched in July 2009, this comprehensive 
program has been co-directed by Paul 
J. DiMuzio, MD, FACS, the William 
M. Measey Professor of Surgery and 
Director of the Division of Vascular and 
Endovascular Surgery. The co-directors are 
Geno Merli, MD, Senior Vice President 
and Chief Medical Officer of Thomas 
Jefferson University Hospital (TJUH), 
and Laurence Needleman, MD, Associate 
Professor of Radiology and Director of the 
Division of Abdominal Imaging.
“The Vascular Center brings these 
specialties together under one roof for 
patients with problems affecting the 
arterial, venous and lymphatic circulatory 
systems,” says Dr. DiMuzio. “Patients can 
get a surgical opinion, have a noninvasive 
vascular study, be cleared preoperatively, 
and have a medical evaluation of an 
issue that doesn’t require surgery—all 
in the same day.” Other programs offer 
these services, he says, but are rarely 
organized under one roof in a way that 
creates a seamless experience for the 
patient. “Our patients receive state-of-
the-art care quickly and efficiently,” Dr. 
DiMuzio says, “from a team of nationally 
and internationally recognized leaders in 
vascular care, research and education.” 
From an arterial standpoint, the center 
specializes in carotid artery disease, 
aortic aneurysm and dissection, and the 
minimally invasive treatment of lower 
Vascular Center Offers Leading-
Edge, Integrated Care
Core members of the Jefferson Vascular Center’s multidisciplinary team. Pictured clockwise 
from left are Co-Director Laurence Needleman, MD; Atul Rao, MD (Surgery); Director Paul J. 
DiMuzio, MD (Surgery); Taki Galanis, MD (Internal Medicine); Joshua Eisenberg, MD (Surgery); 
Walter Kraft, MD (Internal Medicine); and Co-Director Geno Merli, MD (Internal Medicine).
Overview Clinical Integration
Jefferson surgeons are currently assisted by 
an exceptional group of categorical interns. 
These doctors, who recently matched with 
Jefferson, started on June 20, 2010 (l to r):
Meredith Harrison, MD, Drexel University 
Philip Batista, MD, University of Connecticut 
Sean Devitt, MD, Jefferson Medical College 
Meet Our Surgical Interns
Timothy Carter, MD, SUNY Downstate 
Julie Monteagudo, MD, University of Connecticut 
Melanie Sion, MD, Georgetown University
We are also pleased to welcome back  
another Jefferson Medical College graduate,  
Suh Yueh Lim, MD, as a preliminary intern  
in General Surgery. 
extremity atherosclerosis. The physicians 
also evaluate and treat all forms of venous 
disease, including performing minimally 
invasive procedures for varicose veins 
right in the office as well as comprehensive 
evaluation and management of thrombotic 
disorders. Additionally, the center 
includes a comprehensive, on-site wound 
care program centered on hyperbaric 
oxygen therapy. 
The center’s team of physicians currently 
sees close to one hundred patients a 
week, and for the past year Dr. DiMuzio 
and Joshua Eisenberg, MD, FACS 
have performed roughly 80 vascular 
procedures a month. The center’s capacity 
has expanded even further with the 
recruitment of a third vascular surgeon, 
Atul Rao, MD, in August 2010. 
“The full implementation of the Electronic 
Medical Record (EMR) system has 
been a tremendous asset as well,” says 
Dr. DiMuzio. “We can handle a higher 
volume of patients and patient satisfaction 
has been excellent.” The facility, located 
on the sixth floor of the Gibbon Building 
at Jefferson, houses the offices of all six 
physicians, eight exam rooms, three fully 
equipped ultrasound rooms, and the 
hyperbaric oxygen unit. Dr. DiMuzio adds 
that “the difference it has made in our 
patients’ experience is quite noticeable.” 
Read more about the Jefferson  
Vascular Center at www.jeffersonhospital.
org/JVC
“The Vascular Center 
brings these specialties 
together under one roof”
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Dr. Adam Berger Heads New 
Section of Surgical Oncology
Adam Berger, MD, FACS has been named 
Chief of the new Section of Surgical 
Oncology in the Department of Surgery. 
The section’s specialty overlaps with 
several divisions in the Department of 
Surgery and therefore includes surgeons 
specializing in many areas, including 
pancreatic cancer, breast cancer, and 
thyroid cancer. 
Dr. Berger is taking on this latest 
administrative challenge in addition to his 
ongoing clinical, research and educational 
responsibilities. His efforts have not gone 
unnoticed. As a Cancer Liaison Physician 
at Jefferson, Dr. Berger recently received 
an Outstanding Performance Award for 
going above and beyond the scope of 
the normal duties of serving as a liaison 
between the Hospital’s cancer program 
and the American College of Surgeons 
Commission on Cancer. 
As Section Chief, Dr. Berger’s first task 
will be formalizing a surgical oncology 
curriculum for medical students and 
residents. Jefferson will also be applying 
for an NIH T-32 training grant to allow 
one surgical resident to be more formally 
trained in oncologic basic science for  
two years during his or her residency.  
Dr. Berger will be a co-investigator on 
this grant. 
In addition to his clinical and educational 
responsibilities as Section Chief, Dr. 
Berger is the Principal Investigator (PI) 
for a number of national and international 
clinical studies. As a surgeon, Dr. Berger 
feels a responsibility to encourage his 
patients to enroll in clinical trials. “We are 
often the first doctor that a patient sees 
after his or her diagnosis, and we form a 
strong bond,” he says. “Part of my role is 
to advise my patients and emphasize the 
potential impact of their involvement in 
clinical trials for cancer research.” 
One such trial is a randomized 
trial of two surgical techniques for 
pancreaticojejunostomy (connecting 
the pancreas to the jejunum) in patients 
undergoing a Whipple procedure, to 
treat cancerous tumors of the pancreas. 
“There have not been a lot of randomized 
prospective trials on these techniques,” 
says Dr. Berger, “This is the largest 
study to date.” So far the technique that 
favored invagination of the pancreas 
has resulted in fewer pancreatic leaks 
and fewer adverse patient outcomes. 
Dr. Berger presented this research at the 
Annual Meeting of the Southern Surgical 
Association in 2008. 
A second trial for which Dr. Berger is a PI 
studies the use of a new drug– ZD6474–
in combination with chemotherapy and 
radiation prior to surgery for patients 
with esophageal cancer. Dr. Berger 
conceptualized and designed the study  
in consultation with AstraZeneca.  
“Most trials report a pathologically 
complete response rate of about 20 
percent,” says Dr. Berger. “So far, five 
out of eight patients (63 percent) in our 
current trial have had pathologically 
complete responses–meaning the tumor 
has been entirely eliminated–which is  
very encouraging.” 
Dr. Berger is also a surgical 
co-investigator for a multi-institutional 
trial through the Radiation Therapy 
Oncology Group, the first Phase III trial 
to compare the effects of chemotherapy 
and radiation versus chemotherapy alone 
for pancreas cancer patients following 
surgical removal of the head of the 
pancreas. “Unlike in the United States, 
European physicians tend to think the 
combined treatments are worse for the 
patient’s long-term survival and quality 
of life,” says Dr. Berger. Approximately 
900 patients will be enrolled, in Europe, 
Canada, and the United States. “This 
study has been a long time in the 
making,” says Dr. Berger, “but the results 
will be groundbreaking for how we treat 
pancreatic cancer.”
This surgical oncology expertise is now 
accessible beyond the Jefferson Center 
City campus. Dr. Berger provides surgical 
oncology services to Nazareth Hospital 
in Northeast Philadelphia as a part of the 
Jefferson Cancer Network. The Nazareth 
team also includes five Jefferson medical 
oncologists and radiation oncologists. 
Dr. Berger notes, “Our goal is to reach 
out and bring our first-rate care to 
surrounding communities.”
Joseph Cozzitorto, is a Research 
Associate at the Jefferson Center for 
Pancreatic, Biliary and Related Cancers.
How did you come to work at Jefferson?
My wife, Ellen, had been diagnosed with 
pancreatic cancer, and our physician in 
Princeton recommended that we come to 
Jefferson for her surgery. I had worked for 
25 years in the field of molecular biology, 
so during one of our visits, I inquired 
whether the department was doing any 
research. Dr. Yeo thought my experience 
was a good fit for Dr. Jonathan Brody, who 
was about to establish a new lab dedicated 
to pancreatic cancer. That was in 2006, 
and I’ve been commuting from my home in 
South Brunswick, NJ, ever since.
What did your prior experience involve?
I did Plant Molecular Biology, while 
working for EniChem America, an 
Italian startup company and American 
Cyanamid Corporation, which specializes 
in agricultural chemistry. At American 
Cyanamid I isolated genes of agronomic 
interest and generated mutations that 
would allow plants to survive in the 
presence of herbicide. I had also done 
biomedical and basic research in academia 
and for other companies in molecular 
biology. The way I look at it is that every 
other job I’ve had was a preparation for the 
work I do now.
What do you do in Dr. Brody’s lab?
I do cloning work, which involves isolating 
certain genes from cultures of mammalian 
cells or clinical samples of patient tumors 
and inserting them into plasmids so that 
they can be used in experiments. We 
also investigate drug activity in cultured 
cells that have been transfected with 
these genes. I have co-authored several 
articles on our findings. I also manage 
the lab, which includes two residents, a 
PhD investigator, a research assistant, 
and volunteers. As the lab’s Principal 
Investigator, Dr. Brody always has creative 
ideas for experiments that keep the 
projects moving forward. It’s a very team-
oriented environment.
Dr. Berger is heading the new Section of Surgical Oncology at Jefferson in Center City while 
working to expand oncology services to Northeast Philadelphia through Nazareth Hospital. 
At the same time, he is working on formalizing a curriculum and continuing his work on 
several clinical studies.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
Changing Lives Through Research On the Job
“So far, five out of eight 
patients in our current trial 
have had pathologically 
complete responses” 
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The Kristen Olewine 
Milke Breast Cancer 
Research Fund
When Kristen Olewine Milke, a 
Harrisburg native, was diagnosed 
with breast cancer in 2003, she 
sought the best place to have her 
surgery. Her nephew, a surgeon at 
Memorial Sloan-Kettering Cancer 
Center, told her she would receive 
excellent care at Jefferson, and she 
soon became the patient of breast 
surgeon Dr. Ronald Weigel (currently 
the Head of Surgery at the University 
of Iowa) and Clinical Associate 
Professor Steven Copit, MD, who 
performed her reconstructive surgery.
“I became very close to the doctors who 
treated me,” says Ms. Olewine Milke. 
“This was before the Breast Care Center 
had been formalized, but I received 
that same thoughtful, coordinated 
care—where the oncologists, surgeons, 
chemotherapy treatments, and nursing 
care were all seamless. I realized I 
wanted to do more, to have an impact 
on others’ lives.”
Ms. Olewine Milke learned about 
the breast cancer research that 
Dr. Weigel was then doing, a role 
assumed today by Susan Lanza-
Jacoby, PhD. Her work includes 
investigating the possible role of 
diet as well as nonsteroidal anti-
inflammatory drugs (NSAIDs) like 
aspirin and ibuprofen on reducing the 
risk of breast cancer. “I am deeply 
honored that Kristen continues to 
support surgical research, seven 
years after she became my patient,” 
says Dr. Copit. “Her generosity will 
affect how we treat breast cancer 
patients in years to come.”
“It’s great to be able to support the 
ongoing research in the department,” 
she says, “especially given how hard 
it is for researchers to find funding 
today. I don’t have the skills to be a 
researcher myself,” she continues, 
“but it seems only right to try to help, 
out of gratitude for the good care  
I received.”
Ms. Olewine Milke and her father, 
Benjamin Olewine, III, work together 
to support philanthropic causes 
that have special meaning for the 
family, including children’s medicine, 
wildlife conservation, education and 
the arts. Over many decades, Mr. 
Olewine transformed the Harrisburg 
grocery store his father had started 
into a food distribution company that 
was ultimately bought by the Sysco 
Corporation. He turns 89 years old in 
October and continues to go to the 
office each day. Ms. Olewine Milke 
was Senior Vice President of Sysco 
Food Services of Central Pennsylvania 
until 2005, when she retired to devote 
herself full-time to philanthropic work. 
Jefferson is still involved in Ms. 
Olewine Milke’s care seven years 
later. “Were I to need surgery again, 
I would seek out Dr. Copit first and 
foremost,” she says. “In the mean 
time, I’m glad to support Jefferson  
in seeking the best possible  
ways to meet the needs of breast 
cancer patients.”
For additional information about 
planned giving, or to make a 
contribution to the Department  
of Surgery, please contact  
Lara Goldstein in the Jefferson 
Foundation at 215-955-8797 or
lara.goldstein@jefferson.edu.
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Kristen Olewine Milke and her father Benjamin Olewine, III, enjoying 
downtime at a family get together outside of Harrisburg, PA. After 
years of working together at the family business, they now work to 
support philanthropic causes that have special meaning for the family.
Alec C. Beekley, MD, FACS, has joined the Division of Acute 
Care Surgery. Until recently, Dr. Beekley served as a Lieutenant 
Colonel in the U.S. Army Medical Corps stationed at Madigan 
Army Medical Center in Ft. Lewis, Washington. He served as 
a staff surgeon in both Afghanistan and Iraq. His focus will be 
acute care and bariatric surgery.
Jonathan Brody, PhD, has been named the Director of the 
Division of Surgical Research. His research focuses on pancreatic 
cancer and targeted therapies.
Nicholas Cavarocchi, MD, FACS, has joined the Division of 
Cardiothoracic Surgery. Most recently, he served as Director  
of the Heart Transplant Program and the Co-Director of the 
Heart and Vascular Intensive Care Unit at Penn State Milton S.  
Hershey Medical Center. He will serve as the Director of the 
Surgical Critical Care Unit.
Drs. Steven Copit, Eugene Kennedy, and Francis Rosato, Jr. 
each received the Dean’s Award for Excellence in Education  
and Drs. Gerald Isenberg and Barry Mann received the 
Dean’s Citation for Faculty Mentoring at this year’s Faculty 
Awards Dinner. 
George J. Koenig Jr., DO, has joined the Division of Acute Care 
Surgery. Dr. Koenig recently completed a fellowship in Critical 
Care and Acute Care Surgery at the Johns Hopkins Hospital. He 
will provide care at both Jefferson University Hospital and the 
outreach trauma program at Paoli Hospital. 
Stacey Milan, MD, a 2009 graduate of the residency program, 
has joined the Division of General Surgery. Dr. Milan recently 
completed a fellowship in Endocrine Surgery at Yale-New Haven 
Hospital. Her primary focus will be endocrine surgery.
Atul S. Rao, MD, a 2008 graduate of the residency program, has 
joined the Division of Vascular and Endovascular Surgery. Dr. Rao 
recently completed a two-year fellowship in Vascular Surgery at 
the University of Pittsburgh Medical Center. He will provide care 
at both at Jefferson University Hospital and Methodist Hospital. 
Charles J. Yeo, MD, FACS, recently performed his 1,000th 
Whipple procedure—typically performed to treat malignant 
tumors involving the pancreas, common bile duct or duodenum. 
Only one other surgeon in the United States has reached this 
milestone for this procedure.
Find us on Facebook (search for “Surgery at Jefferson”) and follow  
us on Twitter (twitter.com/jeffsurgery)
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